CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-11 | Simon Barry J. See remarks | Sale | −28,068 | $5.50 | $155K | 3,306,838 |
| 2020-03-23 | Nelson Sonja Chief Financial Officer | Option exercise | +15,000 | 36,542 | ||
| 2020-03-23 | Nelson Sonja Chief Financial Officer | Shares withheld for taxes | −6,132 | $2.82 | $17K | 30,410 |
| 2020-03-23 | Nelson Sonja Chief Financial Officer | Option exercise · Restricted Stock Units | −15,000 | 0 | ||
| 2019-12-16 | Thomas John C Director | Sale | −10,000 | $3.14 | $31K | 330,069 |
| 2019-12-13 | Thomas John C Director | Sale | −10,000 | $2.48 | $25K | 350,069 |
| 2019-12-13 | Thomas John C Director | Sale | −10,000 | $2.98 | $30K | 340,069 |
| 2019-12-12 | Thomas John C Director | Sale | −10,000 | $1.99 | $20K | 360,069 |
| 2019-09-09 | Thomas John C Director | Sale | −13,956 | $1.24 | $17K | 370,069 |
| 2019-09-06 | Thomas John C Director | Sale | −7,080 | $1.24 | $9K | 384,025 |
| 2019-09-05 | Thomas John C Director | Sale | −2,964 | $1.25 | $4K | 391,105 |
| 2019-08-02 | Nelson Sonja Chief Financial Officer | Option exercise | +10,000 | 25,000 | ||
| 2019-08-02 | Nelson Sonja Chief Financial Officer | Shares withheld for taxes | −3,458 | $1.27 | $4K | 21,542 |
| 2019-08-02 | Nelson Sonja Chief Financial Officer | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2019-06-06 | Thomas John C Director | Grant or award | +92,592 | 394,069 | ||
| 2019-06-06 | GORLIN STEVE Director | Grant or award | +92,592 | 92,592 | ||
| 2019-06-06 | DRISCOLL FREDERICK W Director | Grant or award | +92,592 | 174,535 | ||
| 2019-06-06 | Cohen Cheryl Director | Grant or award | +300,925 | 300,925 | ||
| 2019-06-06 | BLASZYK MICHAEL D Director | Grant or award | +92,592 | 193,667 | ||
| 2019-03-21 | SOON-SHIONG PATRICK Chairman and CEO | Other acquisition | +17,589,250 | $2.00 | $35.2M | 18,189,250 |
Page 18 of 22 · 433 trades